The spinal cord stimulators (SCS) market has seen significant growth in recent years, and it shows no signs of slowing down. According to the latest data, the market size of spinal cord stimulators was estimated to be USD 1.9 billion in 2021, and it is projected to grow at a CAGR of 8.5 percent during the forecast period. This surge in demand can be attributed to the rising prevalence of chronic pain disorders and technological advancements in the healthcare sector.
The Power of Neuromodulation: Understanding Spinal Cord Stimulators
Spinal cord stimulators, also known as dorsal column stimulators, are cutting-edge neuromodulation tools designed to alleviate chronic pain. These devices are implanted in the body and work by releasing electric signals that block pain signals from reaching the brain. By altering and inhibiting pain impulses before they reach the brain, these gadgets provide much-needed relief to individuals suffering from chronic pain conditions.
A Growing Market: Driving Factors and Opportunities
The market for spinal cord stimulators is set to expand further as chronic disorders become more prevalent. With an increasing number of accidents and traumas leading to spinal operations and treatments, the reported cases of spinal cord injuries (SCI) are on the rise, with 54 cases per million people in the U.S. each year. As the awareness of the benefits of spinal cord stimulation therapy spreads, the market is expected to witness significant growth.
Government programs and policies that offer affordable care to the elderly and underprivileged are also playing a pivotal role in the expansion of the spinal cord stimulation market. Technological advancements, a wide range of healthcare facilities, and non-invasive procedures are driving the growth further. Manufacturers are investing in research and development to meet the increasing demand, leading to the creation of innovative technologies.
Challenges Ahead: Impediments to Market Growth
Despite the optimistic outlook, there are some challenges that the spinal cord stimulators market faces. One significant obstacle is the high cost associated with the implantation of these devices. Depending on factors such as health insurance coverage and annual maintenance expenses, the cost of implanting a spinal cord stimulator can range from $21,000 to $58,000. This can deter potential patients and impact market expansion.
Additionally, complex regional pain syndrome (CRPS) remains a concern, affecting mostly women due to trauma and damage. The rising number of people experiencing chronic pain is another factor driving the market's expansion but can also pose challenges in terms of managing the growing patient count effectively.
Navigating Through COVID-19: Impact on the Spinal Cord Stimulators Market
The COVID-19 pandemic has had a significant impact on the medical industry, including the spinal cord stimulators market. Elective and non-urgent treatments were delayed due to government decisions, slowing down the market expansion. Alongside the pandemic, the industry also faces challenges from product recalls, side effects associated with the devices, and their high prices.
Promising Future: Growth Opportunities and Regional Landscape
The growing elderly population is anticipated to be a major driving force behind the market's growth. With demographic changes leading to an increase in the number of elderly individuals, there is a higher incidence of chronic ailments, such as neurological disorders. Ongoing research and development in spinal cord stimulation technology present further opportunities for growth, with promising projects funded by organizations like the US Defense Advanced Research Projects Agency.
North America currently dominates the global market due to a high level of technological advancement and the presence of well-established healthcare facilities. However, Asia Pacific is expected to witness the highest CAGR during the forecast period, owing to its large proportion of senior citizens and rapid uptake of neuromodulation therapy. Other regions, including the Middle East and Africa, Latin America, and other emerging markets, also hold significant potential for growth.
Leading Players: Competing in the Spinal Cord Stimulators Market
Several key players dominate the spinal cord stimulators market. Among them are Medtronic Public Limited Company, Boston Scientific Corp, St Jude Medical LLC, and Nevro Corp. These companies are driving innovation in the industry, with the Senza Omnia Spinal Cord Stimulation System receiving FDA approval in 2019. Collaborations and mergers, such as the partnership between GTX medical BV and NeuroRecovery Technologies Inc., further contribute to the advancement of neuromodulation therapies.
Conclusion: A Bright Future for Spinal Cord Stimulators
As the prevalence of chronic pain disorders increases, the demand for spinal cord stimulators is expected to surge. Technological advancements, ongoing research, and supportive government policies will fuel market growth. While challenges like high costs and complications may present obstacles, the overall outlook for the spinal cord stimulators market is positive. With promising opportunities in various regions, the industry is poised for significant expansion in the coming years.
Read More: https://www.fairfieldmarketresearch.com/report/spinal-cord-stimulators-market
https://www.xamly.com/spinal-cord-stimulators-market-exploring-future-trends-and-opportunities-2023-2030/
https://hackmd.io/@E4v1isUnROG4-prBVaQQGw/BkWsDFPo3
Contact
Fairfield Market Research
London, UK
UK +44 (0)20 30025888
USA (Toll-free) +1 (844) 3829746
Email: sales@fairfieldmarketresearch.com